NCT04113746

Brief Summary

Develop and pilot test four theory-based educational modules that integrate counseling for asthma and obesity to promote greater physical activity among people with asthma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable asthma

Timeline
Completed

Started Oct 2019

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 3, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

October 3, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2021

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

November 14, 2022

Completed
Last Updated

November 14, 2022

Status Verified

October 1, 2022

Enrollment Period

1.9 years

First QC Date

October 1, 2019

Results QC Date

August 30, 2022

Last Update Submit

October 19, 2022

Conditions

Keywords

AsthmaObesitySelf-management behaviors

Outcome Measures

Primary Outcomes (1)

  • Beliefs About Illness Perception Questionnaire (BIPQ)

    BIPQ includes 5 cognitive domains (Identity, Cause, Timeline, Consequences, and Cure-Control) designed to rapidly assess the cognitive and emotional representations of illness. Each item in each domain is scored on a 0 (none) to 10 (extreme). Full scale from 0-80, where higher score reflects a more threatening view of the illness.

    At 30 days Post-pilot follow-up visit, up to 2 months

Secondary Outcomes (6)

  • Medication Adherence Rating Scale (MARS)

    At 30 days Post-pilot follow-up visit, up to 2 months

  • Physical Activity - Step Counts Per Day

    Week 2, Week 4, and at 30 days Post-pilot follow-up visit

  • Time in Physical Activity

    Week 2, Week 4, and at 30 days Post-pilot follow-up visit

  • Asthma Control Questionnaire (ACQ)

    at 30 days Post-pilot follow-up visit, up to 2 months

  • Asthma Quality of Life Questionnaire (AQLQ)

    at 30 days post-pilot follow-up visit, up to 2 months

  • +1 more secondary outcomes

Study Arms (2)

Asthma and Exercise Lifestyle Change

EXPERIMENTAL

Participants receive asthma and lifestyle change education related to exercise

Behavioral: Better asthma self-management and incorporation of physical activity

Asthma Education

PLACEBO COMPARATOR

No lifestyle change education

Behavioral: Asthma Education

Interventions

Participants in the asthma and exercise lifestyle change arm will participate in 4 sessions focused on behavioral change and goal-setting education to teach them how to better incorporate exercise into their daily lives and better manage their asthma. Following sessions 1 and 4, these participants will use the accelerometer to track activity, but will be blinded to the data.

Asthma and Exercise Lifestyle Change

General asthma education, but no discussion of the role of exercise and other lifestyle habits in asthma self-management. Following sessions 1 and 4, these participants will use the accelerometer to track activity, but will be blinded to the data.

Asthma Education

Eligibility Criteria

Age21 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years of age
  • BMI ≥ 30
  • Asthma diagnosis made by a health care provider
  • Poor Asthma Control (ACQ score ≥ 0.75)
  • English speaking

You may not qualify if:

  • BMI \< 30
  • Good asthma control (ACQ score \<0.75)
  • Diagnosis of dementia
  • Diagnosis of chronic obstructive pulmonary disease (COPD) or other chronic respiratory illness
  • Smoking history of ≥15 pack-years owing to possible undiagnosed COPD

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Colorado Denver, Anschutz Medical Campus

Aurora, Colorado, 80045, United States

Location

Icahn School of Medicine at Mount Sinai

New York, New York, 10029, United States

Location

MeSH Terms

Conditions

AsthmaObesity

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Juan P. Wisnivesky, MD, DrPH
Organization
Icahn School of Medicine at Mount Sinai

Study Officials

  • Juan P. Wisnivesky, MD, DrPH

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR
  • Alex D. Federman, MD, MPH

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR
  • Fernando Holguin, MD, MPH

    University of Colorado Denver, Anschutz Medical Campus

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The Research Coordinator who is administering the follow-up survey will be masked
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 1, 2019

First Posted

October 3, 2019

Study Start

October 3, 2019

Primary Completion

August 30, 2021

Study Completion

August 30, 2021

Last Updated

November 14, 2022

Results First Posted

November 14, 2022

Record last verified: 2022-10

Locations